Clinical trial
Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced…
NCT00305825 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00305825 |
|---|---|
| Title | Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery |
| Official title | A Phase II Study of Letrozole in Combination With Bevacizumab in Patients With Estrogen Receptor- and/or Progesterone Receptor-Positive Unresectable Locally Advanced and/or Metastatic (Stage IV) Breast Cancer |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH Memorial Sloan Kettering Cancer Center |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug |
| Interventions | bevacizumab, letrozole |
| Enrollment | 43 |
| Start date | Aug 1, 2004 |
| Primary completion | May 30, 2006 |
| Completion | May 24, 2016 |
| First posted | Mar 22, 2006 |
| Last update posted | Aug 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: